https://www.selleckchem.com/pr....oducts/vx803-m4344.h
© 2020 John Wiley Sons Ltd.A pathologic complete response (pCR) in the axilla occurs in 30%-40% of patients with initially node-positive breast cancer after neo-adjuvant chemotherapy (NACT). Debate persists about whether to perform systematic axillary lymphadenectomy (ALND) in patients with initial node-positive disease and clinical complete response after NACT. We aimed to identify predictive factors of axillary pCR (ypN after NACT. This retrospective study analyzed data for all patients with initial biopsy-proven node-posi
Like
Comment
Share
